75% of men and 35% of women are affected by hair-loss.
keratinised cells, which in turn produces a shorter, thinner hair shaft. Consequently the hair follicle miniaturises and shifts back into the resting phase, giving rise to the term 'male and female pattern hair loss' - a condition referred to by medics as Androgenetic Alopecia.
The Laser uses 171 APC Controlled 5mW, 650 nm laser diodes exactly in line with the 2007 FDA Clinical Trial specification. The laser beam penetrates the hair follicle to the dermal papillae. The ensuing cascade of events helps kick start the mitochondria into converting ADP to ATP, providing energy for renewed cell division in the matrix. In this way, laser therapy stimulates cellular metabolism whilst drastically increases circulation which reverses the cycle of follicular miniaturisation.
The outcome of this process is an increase in the production keratinised cells, thus an increase in the thickness and strength of the hair shaft.